ro 46-2005 has been researched along with arginine in 1 studies
Studies (ro 46-2005) | Trials (ro 46-2005) | Recent Studies (post-2010) (ro 46-2005) | Studies (arginine) | Trials (arginine) | Recent Studies (post-2010) (arginine) |
---|---|---|---|---|---|
26 | 0 | 1 | 46,388 | 1,688 | 11,176 |
Protein | Taxonomy | ro 46-2005 (IC50) | arginine (IC50) |
---|---|---|---|
Cationic amino acid transporter 3 | Homo sapiens (human) | 283 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breu, V; Clozel, M; Gray, GA; Löffler, BM | 1 |
1 other study(ies) available for ro 46-2005 and arginine
Article | Year |
---|---|
In vivo pharmacology of Ro 46-2005, the first synthetic nonpeptide endothelin receptor antagonist: implications for endothelin physiology.
Topics: Anesthesia; Animals; Arginine; Blood Pressure; Endothelin Receptor Antagonists; Endothelins; Heart Rate; In Vitro Techniques; Injections, Intravenous; Male; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyrimidines; Rats; Rats, Wistar; Sulfonamides | 1993 |